ATE279407T1 - Fsh mimetika zur behandlung von infertilität - Google Patents
Fsh mimetika zur behandlung von infertilitätInfo
- Publication number
- ATE279407T1 ATE279407T1 AT99939686T AT99939686T ATE279407T1 AT E279407 T1 ATE279407 T1 AT E279407T1 AT 99939686 T AT99939686 T AT 99939686T AT 99939686 T AT99939686 T AT 99939686T AT E279407 T1 ATE279407 T1 AT E279407T1
- Authority
- AT
- Austria
- Prior art keywords
- infertility
- treatment
- fsh mimetics
- fsh
- mimetics
- Prior art date
Links
- 208000000509 infertility Diseases 0.000 title 1
- 230000036512 infertility Effects 0.000 title 1
- 231100000535 infertility Toxicity 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9571298P | 1998-08-07 | 1998-08-07 | |
| PCT/US1999/017755 WO2000008015A2 (en) | 1998-08-07 | 1999-08-05 | Fsh mimetics for the treatment of infertility |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE279407T1 true ATE279407T1 (de) | 2004-10-15 |
Family
ID=22253270
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99939686T ATE279407T1 (de) | 1998-08-07 | 1999-08-05 | Fsh mimetika zur behandlung von infertilität |
| AT03023514T ATE329911T1 (de) | 1998-08-07 | 1999-08-05 | Fsh mimetika zur behandlung von infertilität |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03023514T ATE329911T1 (de) | 1998-08-07 | 1999-08-05 | Fsh mimetika zur behandlung von infertilität |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US6235755B1 (de) |
| EP (1) | EP1102763B1 (de) |
| JP (1) | JP4511042B2 (de) |
| AR (1) | AR021755A1 (de) |
| AT (2) | ATE279407T1 (de) |
| AU (1) | AU772373B2 (de) |
| CA (1) | CA2339018A1 (de) |
| DE (2) | DE69921147T2 (de) |
| ES (2) | ES2228084T3 (de) |
| IL (1) | IL141063A (de) |
| PT (2) | PT1102763E (de) |
| WO (1) | WO2000008015A2 (de) |
Families Citing this family (77)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6025355A (en) * | 1997-05-19 | 2000-02-15 | Cambridge Neuroscience, Inc. | Pharmaceutically active compounds and methods of use |
| WO2000047207A1 (en) | 1999-02-09 | 2000-08-17 | Bristol-Myers Squibb Company | LACTAM INHIBITORS OF FXa AND METHOD |
| HRP20020705A2 (en) | 2000-03-27 | 2004-12-31 | Applied Research Systems | Pharmaceutically active pyrrolidine derivatives |
| US7018988B2 (en) | 2000-03-27 | 2006-03-28 | Applied Research Systems Ars Holding N.V. | Pharmaceutically active pyrrolidine derivatives as Bax inhibitors |
| GB0010757D0 (en) | 2000-05-05 | 2000-06-28 | Astrazeneca Ab | Chemical compounds |
| US6511973B2 (en) | 2000-08-02 | 2003-01-28 | Bristol-Myers Squibb Co. | Lactam inhibitors of FXa and method |
| US6900213B2 (en) | 2001-01-19 | 2005-05-31 | Pharmacopeia Drug Discovery, Inc. | Bisaryl derivatives having FSH modulatory activity |
| DE60201415T2 (de) * | 2001-01-19 | 2006-02-09 | Pharmacopeia, Inc. | Bisarylderivate mit fsh rezeptor modulierender aktivität |
| MXPA03007621A (es) | 2001-02-23 | 2003-12-04 | Merck & Co Inc | Antagonistas nr2b de n-metil-d-aspartato no arilheterociclicos n-sustituidos. |
| EP1390034A4 (de) | 2001-04-03 | 2005-07-13 | Merck & Co Inc | N-substituierte nonaryl-heterocyclo amidyl-nmda/nr2b-antagonisten |
| BR0209334A (pt) | 2001-05-05 | 2004-06-15 | Smithkline Beecham Plc | Aminas n-aroil cìclicas |
| GB0115862D0 (en) * | 2001-06-28 | 2001-08-22 | Smithkline Beecham Plc | Compounds |
| CA2452606C (en) * | 2001-07-02 | 2011-09-13 | Akzo Nobel N.V. | Tetrahydroquinoline derivatives |
| GB0121941D0 (en) | 2001-09-11 | 2001-10-31 | Astrazeneca Ab | Chemical compounds |
| IL161235A0 (en) * | 2001-10-22 | 2004-09-27 | Applied Research Systems | Fsh composition, its preparation and use |
| CA2499732A1 (en) * | 2002-09-20 | 2004-04-15 | Applied Research Systems Ars Holding N.V. | Piperazine derivatives and methods of use |
| TWI306855B (en) * | 2002-12-20 | 2009-03-01 | Organon Nv | Tetrahydroquinoline derivatives |
| TWI322012B (en) * | 2002-12-20 | 2010-03-21 | Organon Nv | Tetrahydroquinoline derivatives |
| CN100386318C (zh) * | 2002-12-20 | 2008-05-07 | 欧加农股份有限公司 | 四氢喹啉衍生物及其作为fsh受体调节剂的用途 |
| CN100404508C (zh) * | 2002-12-20 | 2008-07-23 | 欧加农股份有限公司 | 四氢喹啉衍生物 |
| UA88879C2 (en) * | 2003-09-02 | 2009-12-10 | Эплайд Рисерч Системз Эрс Холдинг Н.В. | Fsh glycosylation mutant |
| CA2553187A1 (en) * | 2004-01-28 | 2005-08-11 | Syntonix Pharmaceuticals, Inc. | Heterodimeric follicle stimulating hormone-fc (fsh-fc) fusion proteins for the treatment of infertility |
| US7691848B2 (en) | 2005-03-02 | 2010-04-06 | Wyeth | Pyrrolobenzodiazepine arylcarboxamides and derivatives thereof as follicle-stimulating hormone receptor antagonists |
| JPWO2006095922A1 (ja) * | 2005-03-10 | 2008-08-21 | 京都薬品工業株式会社 | テトラヒドロイソキノリン化合物およびその医薬用途 |
| UA92008C2 (en) | 2005-05-04 | 2010-09-27 | Н.В. Органон | 4-PHENYL-5-OXO-l,4,5,6,7,8-HEXAHYDROQUINOLINE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF INFERTILITY |
| UA92009C2 (ru) | 2005-05-04 | 2010-09-27 | Н.В. Органон | Производные 4-фенил-5-оксо-1,4,5,6,7,8-гексагидрохинолина для лечения бесплодия |
| CN101171234B (zh) | 2005-05-04 | 2011-11-16 | 欧加农股份有限公司 | 二氢吡啶衍生物 |
| UA92007C2 (ru) | 2005-05-04 | 2010-09-27 | Н.В. Органон | Производные 4-фенил-5-оксо-1,4,5,6,7,8-гексагидрохинолина для лечения бесплодности |
| EP1879898A2 (de) | 2005-05-12 | 2008-01-23 | Wyeth a Corporation of the State of Delaware | Pyrrolobenzodiazepine und heterozyklische carboxamid-derivate als follikelstimulierende hormonrezeptor-antagonisten |
| CN101208342A (zh) | 2005-06-09 | 2008-06-25 | 惠氏公司 | 作为促卵泡激素受体拮抗剂的吡咯并苯并二氮杂䓬吡啶羧酰胺和衍生物 |
| US20090018142A9 (en) * | 2006-05-02 | 2009-01-15 | Zhengping Zhuang | Use of phosphatases to treat tumors overexpressing N-CoR |
| WO2007136776A2 (en) * | 2006-05-17 | 2007-11-29 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Pyrimidine low molecular weight ligands for modulating hormone receptors |
| WO2008014199A2 (en) | 2006-07-28 | 2008-01-31 | Boehringer Ingelheim International Gmbh | Sulfonyl compounds which modulate the cb2 receptor |
| BRPI0806365B8 (pt) * | 2007-02-06 | 2021-05-25 | Lixte Biotechnology Holdings Inc | composto, uso do composto, composição farmacêutica e uso da composição farmacêutica |
| CA2700857C (en) | 2007-10-01 | 2016-08-02 | John S. Kovach | Hdac inhibitors |
| EP2217565B1 (de) | 2007-11-07 | 2013-05-22 | Boehringer Ingelheim International GmbH | Cb2 rezeptor-modulierende verbindungen |
| TW200944523A (en) * | 2008-02-08 | 2009-11-01 | Organon Nv | (Dihydro)pyrrolo[2,1-a]isoquinolines |
| EP2326629B1 (de) | 2008-07-10 | 2013-10-02 | Boehringer Ingelheim International GmbH | Den cb2-rezeptor modulierende sulfonverbindungen |
| US8227473B2 (en) | 2008-08-01 | 2012-07-24 | Lixte Biotechnology, Inc. | Oxabicycloheptanes and oxabicycloheptenes, their preparation and use |
| WO2010014220A1 (en) | 2008-08-01 | 2010-02-04 | Lixte Biotechnology, Inc. | Neuroprotective agents for the prevention and treatment of neurodegenerative diseases |
| WO2010147612A1 (en) | 2009-06-18 | 2010-12-23 | Lixte Biotechnology, Inc. | Methods of modulating cell regulation by inhibiting p53 |
| CA2737645A1 (en) | 2008-09-25 | 2010-04-01 | Boehringer Ingelheim International Gmbh | Compounds which selectively modulate the cb2 receptor |
| CA2749163A1 (en) | 2009-01-14 | 2010-07-22 | The Salk Institute For Biological Studies | Methods for screening and compounds that protect against amyloid diseases |
| EP2398771B1 (de) | 2009-02-18 | 2015-07-29 | Boehringer Ingelheim International GmbH | Den cb2-rezeptor modulierende heterocyclische verbindungen |
| US8071587B2 (en) | 2009-05-27 | 2011-12-06 | N. V. Organon | (Dihydro)imidazoiso[5,1-A]quinolines |
| TWI461426B (zh) * | 2009-05-27 | 2014-11-21 | Merck Sharp & Dohme | (二氫)咪唑並異〔5,1-a〕喹啉類 |
| US8299103B2 (en) | 2009-06-15 | 2012-10-30 | Boehringer Ingelheim International Gmbh | Compounds which selectively modulate the CB2 receptor |
| WO2010147791A1 (en) * | 2009-06-16 | 2010-12-23 | Boehringer Ingelheim International Gmbh | Azetidine 2 -carboxamide derivatives which modulate the cb2 receptor |
| US8431564B2 (en) | 2009-07-29 | 2013-04-30 | Merck Sharp & Dohme B.V. | Ring-annulated dihydropyrrolo[2,1-α]isoquinolines |
| TW201116531A (en) | 2009-07-29 | 2011-05-16 | Organon Nv | Ring-annulated dihydropyrrolo[2,1-a]isoquinolines |
| TW201116515A (en) * | 2009-07-31 | 2011-05-16 | Organon Nv | Dihydrobenzoindazoles |
| USRE46608E1 (en) | 2009-09-01 | 2017-11-14 | Catabasis Pharmaceuticals, Inc. | Fatty acid niacin conjugates and their uses |
| DK2473045T3 (en) | 2009-09-01 | 2016-12-12 | Catabasis Pharmaceuticals Inc | Niacin-FATTY ACID CONJUGATES AND THEIR USES |
| EP2480544A1 (de) | 2009-09-22 | 2012-08-01 | Boehringer Ingelheim International GmbH | Verbindungen für selektive cb2-rezeptormodulation |
| EP2523936A1 (de) | 2010-01-15 | 2012-11-21 | Boehringer Ingelheim International GmbH | Cb2 rezeptor-modulierende verbindungen |
| US8329735B2 (en) | 2010-03-05 | 2012-12-11 | Boehringer Ingelheim International Gmbh | Tetrazole compounds which selectively modulate the CB2 receptor |
| WO2012012307A1 (en) | 2010-07-22 | 2012-01-26 | Boehringer Ingelheim International Gmbh | Sulfonyl compounds which modulate the cb2 rece |
| JP6170043B2 (ja) * | 2011-07-01 | 2017-07-26 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung | ジヒドロピラゾール |
| WO2013012848A1 (en) | 2011-07-18 | 2013-01-24 | Merck Patent Gmbh | Benzamides |
| ES2663972T3 (es) | 2012-01-10 | 2018-04-17 | Merck Patent Gmbh | Derivados de benzamida como moduladores de la hormona folículo estimulante |
| KR20140120903A (ko) | 2012-02-08 | 2014-10-14 | 메르크 파텐트 게엠베하 | 여포 자극 호르몬수용체의 아고니스트로서 중수소화 티아졸리디논 유사체 |
| KR20160004299A (ko) | 2013-04-09 | 2016-01-12 | 릭스트 바이오테크놀로지, 인코포레이티드 | 옥사바이시클로헵탄류 및 옥사바이시클로헵텐류의 제형 |
| EP2803668A1 (de) | 2013-05-17 | 2014-11-19 | Boehringer Ingelheim International Gmbh | Neuartige (Cyano-dimethyl-methyl)-isoxazole und -[1,3,4]-thiadiazole |
| RU2663898C2 (ru) | 2013-06-24 | 2018-08-13 | Мерк Патент Гмбх | Пиразольные соединения в качестве модуляторов fshr и их применение |
| EP3013823B1 (de) | 2013-06-24 | 2017-11-01 | Merck Patent GmbH | Imidazolverbindungen als modulatoren von fshr und verwendungen davon |
| US11433047B2 (en) | 2015-10-09 | 2022-09-06 | Neurotheryx Canada Ltd. | Pharmaceutical compositions comprising one or more pyrone compounds, and their use for treating inflammatory and neurodegenerative diseases |
| AU2017370731B2 (en) | 2016-12-08 | 2022-06-02 | Lixte Biotechnology, Inc. | Oxabicycloheptanes for modulation of immune response |
| US10729689B2 (en) * | 2017-10-26 | 2020-08-04 | University Of Puerto Rico | Carbazole EHop-016 derivatives as anti-cancer and anti-migratory agents |
| CR20220178A (es) | 2019-10-25 | 2022-06-15 | Gilead Sciences Inc | Compuestos moduladores de glp-1r |
| SI4097097T1 (sl) | 2020-01-29 | 2025-04-30 | Gilead Sciences, Inc. | Spojine, ki modulirajo glp-1r |
| EP4247804A1 (de) | 2020-11-20 | 2023-09-27 | Gilead Sciences, Inc. | Polyheterocyclische glp-1 r modulierende verbindungen |
| EP4284804A1 (de) | 2021-01-26 | 2023-12-06 | Schrödinger, Inc. | Tricyclische verbindungen zur behandlung von krebs, autoimmun- und entzündungserkrankungen |
| EP4304711A1 (de) | 2021-03-11 | 2024-01-17 | Gilead Sciences, Inc. | Verbindungen zur glp-1r-modulation |
| US12180197B2 (en) | 2021-03-11 | 2024-12-31 | Gilead Sciences, Inc. | GLP-1R modulating compounds |
| LT4271672T (lt) | 2021-04-21 | 2026-03-10 | Gilead Sciences, Inc. | Karboksibenzimidazolo junginiai, moduliuojantys glp-1r |
| WO2024184461A2 (en) | 2023-03-08 | 2024-09-12 | Ferring B.V. | Small molecule fsh receptor modulators |
| CN117510475A (zh) * | 2023-11-01 | 2024-02-06 | 江苏缘龙医院管理有限责任公司 | 干扰RNA-蛋白相互作用的Musashi蛋白抑制剂及其应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3947569A (en) * | 1972-04-12 | 1976-03-30 | American Home Products Corporation | Process for preparing the releasing hormone of luteinizing hormone (LH) and of follicle stimulating hormone (FSH), salts and compositions thereof, and intermediates therefor |
| JPS5331669A (en) * | 1976-09-06 | 1978-03-25 | Kissei Pharmaceut Co Ltd | Novel n-acylpiperidinecaroxyanilide derivatives and their preparation |
| DE3636278A1 (de) * | 1986-10-24 | 1988-05-05 | Hoechst Ag | Herbizide mittel auf der basis von cyclischen (alpha)-iminocarbon-saeureaniliden sowie neue (alpha)-iminocarbonsaeureanilide und verfahren zu ihrer herstellung |
| US4800432A (en) * | 1986-10-24 | 1989-01-24 | The Grass Valley Group, Inc. | Video Difference key generator |
| US5071823A (en) | 1988-10-12 | 1991-12-10 | Mitsubishi Paper Mills Limited | Image-receiving sheet for transfer recording |
| DE3842010A1 (de) * | 1988-12-14 | 1990-06-21 | Hoechst Ag | Kompetitive gonadoliberin-antagonisten |
| JPH07501085A (ja) * | 1992-09-03 | 1995-02-02 | ベーリンガー インゲルハイム コマンディトゲゼルシャフト | 新規なアミノ酸誘導体、その製造方法及びこれらの化合物を含む医薬組成物 |
| US5455229A (en) * | 1992-12-23 | 1995-10-03 | Eli Lilly And Company | Method for minimizing and containing ischemic and reperfusion injury |
| PE45195A1 (es) * | 1994-03-03 | 1996-01-17 | Boehringer Ingelheim Kg | Derivado de aminoacido, procedimiento para su preparacion y composicion farmaceutica que lo contiene |
| AU753540B2 (en) * | 1998-03-05 | 2002-10-24 | Agouron Pharmaceuticals, Inc. | Non-peptide GnRH agents |
-
1999
- 1999-08-05 WO PCT/US1999/017755 patent/WO2000008015A2/en not_active Ceased
- 1999-08-05 EP EP99939686A patent/EP1102763B1/de not_active Expired - Lifetime
- 1999-08-05 JP JP2000563648A patent/JP4511042B2/ja not_active Expired - Fee Related
- 1999-08-05 PT PT99939686T patent/PT1102763E/pt unknown
- 1999-08-05 AU AU53931/99A patent/AU772373B2/en not_active Ceased
- 1999-08-05 IL IL14106399A patent/IL141063A/xx not_active IP Right Cessation
- 1999-08-05 AT AT99939686T patent/ATE279407T1/de active
- 1999-08-05 DE DE69921147T patent/DE69921147T2/de not_active Expired - Lifetime
- 1999-08-05 AT AT03023514T patent/ATE329911T1/de active
- 1999-08-05 CA CA002339018A patent/CA2339018A1/en not_active Abandoned
- 1999-08-05 ES ES99939686T patent/ES2228084T3/es not_active Expired - Lifetime
- 1999-08-05 US US09/369,222 patent/US6235755B1/en not_active Expired - Lifetime
- 1999-08-05 ES ES03023514T patent/ES2261844T3/es not_active Expired - Lifetime
- 1999-08-05 DE DE69931975T patent/DE69931975T2/de not_active Expired - Lifetime
- 1999-08-06 AR ARP990103937A patent/AR021755A1/es active IP Right Grant
- 1999-08-08 PT PT03023514T patent/PT1380582E/pt unknown
-
2000
- 2000-11-28 US US09/723,495 patent/US6423723B1/en not_active Expired - Fee Related
-
2002
- 2002-05-28 US US10/156,431 patent/US6653338B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ES2228084T3 (es) | 2005-04-01 |
| PT1102763E (pt) | 2005-01-31 |
| AU772373B2 (en) | 2004-04-22 |
| PT1380582E (pt) | 2006-08-31 |
| ES2261844T3 (es) | 2006-11-16 |
| AU5393199A (en) | 2000-02-28 |
| WO2000008015A3 (en) | 2000-05-11 |
| US20020147345A1 (en) | 2002-10-10 |
| US6653338B2 (en) | 2003-11-25 |
| US6235755B1 (en) | 2001-05-22 |
| AR021755A1 (es) | 2002-08-07 |
| EP1102763B1 (de) | 2004-10-13 |
| JP2002522433A (ja) | 2002-07-23 |
| IL141063A (en) | 2005-06-19 |
| CA2339018A1 (en) | 2000-02-17 |
| JP4511042B2 (ja) | 2010-07-28 |
| DE69921147T2 (de) | 2005-02-24 |
| EP1102763A2 (de) | 2001-05-30 |
| US6423723B1 (en) | 2002-07-23 |
| WO2000008015A2 (en) | 2000-02-17 |
| DE69931975T2 (de) | 2006-10-05 |
| DE69921147D1 (de) | 2004-11-18 |
| DE69931975D1 (de) | 2006-07-27 |
| IL141063A0 (en) | 2002-02-10 |
| ATE329911T1 (de) | 2006-07-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE329911T1 (de) | Fsh mimetika zur behandlung von infertilität | |
| DE69936890D1 (de) | Vorrichtung zur Behandlung von Ischämie | |
| DE69928542D1 (de) | 5ht2-agoniste zur behandlung des glaukoms | |
| ATE235236T1 (de) | Unsubstituierte polydiallylaminen zur behandlung von hypercholesterolemia | |
| DE59712045D1 (de) | Vorrichtung zur behandlung des herzens | |
| DE69924750D1 (de) | Gerät zur thermischen behandlung von gewebe | |
| DE69732152D1 (de) | Vorrichtung zur Behandlung von Kopfschmerzen | |
| EP0709090A3 (de) | Zusammensetzungen zur Behandlung von resistenten Tumoren | |
| DE60019158D1 (de) | Neue oxabispidin-verbindungen zur behandlung von herzarrhythmien | |
| NO992237D0 (no) | Vannbehandlingsprosess | |
| DE60136477D1 (de) | Retinoide zur behandlung von emphysem | |
| ATE279386T1 (de) | Retinoide zur behandlung von emphysem | |
| DE69835419D1 (de) | Verfahren zur Behandlung von organischem Abwasser | |
| DE69943089D1 (de) | Methode zur behandlung von staphylokokkeninfektionen | |
| ATE344661T1 (de) | Rar-gamma selektive retinoid-agonisten zur behandlung von emphysemen | |
| DE60224650D1 (de) | Vorrichtung zur behandlung von vorhof-fibrillation | |
| ATE347372T1 (de) | Vakzine zur behandlung von mycosen | |
| ATE222910T1 (de) | Triptolid-derivate nützlich zur behandlung von autoimmunkrankheiten | |
| DE69926485D1 (de) | Behandlung von durchblasgasen | |
| DE60021252D1 (de) | Antikonvulsiva zur behandlung von autismus | |
| DE69834937D1 (de) | Antibiotika zur behandlung von magengeschwuren | |
| ATE250580T1 (de) | Substituierte pyridino-arylpiperazine zur behandlung benigner prostatahyperplasie | |
| ATE230741T1 (de) | 3-tetrahydropyridin-4-yl-indole zur behandlung von psychotischen störungen | |
| NO20003481D0 (no) | FremgangsmÕte for behandling av COPD | |
| DE69802498D1 (de) | Idebenon enthaltendes kombinationspräparat zur alzheimer behandlung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1102763 Country of ref document: EP |
|
| EEFA | Change of the company name |